Objective:
To share emerging therapies and surgical approaches in retina care during the 50th Atlantic Coast Retina Club and Macula conference, marking a significant milestone in the field.
Approach:
- Significant drop in systemic cell-free DNA after enucleation in a retinoblastoma case led to intra-arterial chemotherapy decision.
- Intra-arterial chemotherapy was effective for metastatic cutaneous melanoma in the subretinal space.
- A case of choroidal thickening in a diabetic patient resolved after discontinuing dulaglutide, highlighting the need for understanding GLP-1 receptor agonists' ocular side effects.
- Inflammatory mimickers of retinal diseases were discussed, emphasizing the need for comprehensive evaluations.
- Emerging therapies like intravitreal tyrosine kinase inhibitors show promise in treating diabetic retinopathy.
- The conference was limited to presentations and discussions, lacking extensive longitudinal data on the emerging therapies, which may affect the reliability of the findings.
- Real-world applicability of discussed therapies may vary and requires further validation through clinical trials.
Key Findings:
Interpretation:
The conference highlighted the importance of case-based learning and the evolving landscape of retinal therapies, emphasizing the need for ongoing education and adaptation in clinical practice.
Limitations:
Conclusion:
The Atlantic Coast Retina Club and Macula 2026 conference served as a significant platform for sharing knowledge and advancements in retinal care, reinforcing the importance of continuous learning in the field through case studies and expert insights.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
